Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Some biosimilars are just as good as some pricey biologics

A new study suggests that a group of biosimilar drugs, which are used to treat such afflictions as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, appear as safe and effective as their more expensive brand-name counterparts, which are known as biologics. A biosimilar drug is a nearly identical variant of a biologic and is expected to…

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact us or visit www.DrugPatentWatch.com

Back to DrugPatentWatch Resources

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc